Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Triblend 1mg/500mg/15mg Tablet is used in the treatment of type 2 diabetes.
10 tablets in 1 strip
Akesiss Pharma Pvt Ltd
Image shown is a representation and may slightly vary from the actual product. Every effort is made to maintain accuracy of all information displayed.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Triblend 1mg/500mg/15mg Tablet is to be taken with food.
Triblend 1mg/500mg/15mg Tablet may cause stomach upset if taken empty stomach.
Triblend 1mg/500mg/15mg Tablet is a combination of three antidiabetic medicines: Glimepiride, Metformin and Pioglitazone. They work by different mechanisms to provide better control of blood sugar when single or dual therapy is not effective. Glimepiride is a sulfonylurea which works by increasing the amount of insulin released by the pancreas in order to lower the blood glucose. Metformin is a biguanide. It works by lowering glucose production in the liver, delaying glucose absorption from intestines and increasing the body"s sensitivity to insulin. Pioglitazone is a thiazolidinedione which further increases insulin sensitivity.
Related Warnings
Taking pioglitazone with alcohol may affect blood glucose levels in patients with diabetes.
Triblend 1mg/500mg/15mg Tablet may be unsafe to use during pregnancy.
Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
Triblend 1mg/500mg/15mg Tablet is probably safe to use during lactation. Limited human data suggests that the drug does not represent a significant risk to the baby.
Monitor the breastfed baby’s blood sugar during treatment with Triblend 1mg/500mg/15mg Tablet
Your ability to drive may be affected if your blood sugar is low or high. If this happens, do not drive.
Triblend 1mg/500mg/15mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Triblend 1mg/500mg/15mg Tablet may be needed. Please consult your doctor.
Use of Triblend 1mg/500mg/15mg Tablet is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Triblend 1mg/500mg/15mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Triblend 1mg/500mg/15mg Tablet may be needed. Please consult your doctor.
Use of Triblend 1mg/500mg/15mg Tablet is not recommended in patients with severe liver disease.
